SAGE Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing and commercializing medicines to treat central nervous system (CNS) disorders.

Biotechnology

Sage Therapeutics

Sage Therapeutics' headquarters in Cambridge, MA, United States

Barry E. Greene

Jessica Johnson Brock

Lisa Lopez

Taryn Westerkamp

Erin Flaherty

Jason Valdivia

Anne Marie Cook

Tammy Phinney

Ruta Sawant

Etchell Cordero

Matthew Henson

Liz Barrett

Michael F. Cola

James M. Frates

George Golumbeski

Jessica Federer

The Data Management and Analysis team at Sage Therapeutics is responsible for overseeing the integrity and quality of clinical data throughout the drug development process. This team collaborates with clinical operations, biostatistics, and digital integration teams to ensure accurate data collection, analysis, and reporting for CNS disorder treatments. They leverage advanced data science techniques to derive insights and support decision-making, ultimately enhancing the efficiency and effectiveness of clinical trials.

Data Management and Analysis

The Market Access and Patient Support team at Sage Therapeutics focuses on ensuring that patients have timely access to innovative CNS therapies. They develop strategies for market access, engage with payers and healthcare providers, and implement patient support programs tailored to optimize the treatment journey. This collaborative team works to navigate reimbursement processes, enhance patient recruitment and retention, and ensure compliance, ultimately aiming to improve patient outcomes and healthcare accessibility.

Market Access and Patient Support

The Clinical Operations and Development team at Sage Therapeutics is focused on managing and executing clinical trials for innovative CNS therapies. This team coordinates study protocols, oversees regulatory compliance, collaborates with external partners, and ensures that clinical data is accurately collected and analyzed to support the development of effective treatments. Additionally, they work on optimizing operational processes to enhance efficiency and streamline communication among stakeholders throughout the clinical development lifecycle.

Clinical Operations and Development

The Leadership Team at Sage Therapeutics plays a critical role in guiding the company's strategic direction and operational effectiveness in the development of treatments for CNS disorders. Comprising executives from various disciplines, including research and development, legal, business operations, and human resources, this team collaborates to ensure alignment with the company’s mission, oversee the advancement of innovative therapies, and foster a culture of excellence and collaboration within the organization.

Leadership Team

The Quality Assurance and Compliance team at Sage Therapeutics is responsible for ensuring that all processes and products meet regulatory standards and internal quality benchmarks throughout the drug development lifecycle. This team oversees compliance with Good Laboratory Practices (GLP) and Good Manufacturing Practices (GMP), develops and maintains quality systems, and conducts training to uphold the highest standards of safety and effectiveness in the development of treatments for CNS disorders. Their efforts ensure that the company's products are safe for clinical use and align with industry regulations.

Sage Therapeutics

Org chart

Board & advisors

Teams

Data Management and Analysis

Market Access and Patient Support

Clinical Operations and Development

Leadership Team

Quality Assurance and Compliance

Offices

Sage Therapeutics

Org chart

Board & advisors

Teams

Data Management and Analysis

Market Access and Patient Support

Clinical Operations and Development

Leadership Team

Quality Assurance and Compliance

Offices

Related companies